Mark Plinio - Jun 14, 2021 Form 4 Insider Report for Evelo Biosciences, Inc. (EVLO)

Role
Chief Commercial Officer
Signature
/s/ Daniel S. Char, Attorney-in-Fact for Mark D. Plinio
Stock symbol
EVLO
Transactions as of
Jun 14, 2021
Transactions value $
$0
Form type
4
Date filed
6/16/2021, 04:18 PM
Next filing
Jan 21, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVLO Stock Option (Right to Buy) Award $0 +250K $0.00 250K Jun 14, 2021 Common Stock 250K $16.34 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of underlying shares will vest on 1st anniversary of employment commencement date (i.e., June 14, 2022), and remaining 75% of underlying shares will vest in 36 substantially equal monthly installments thereafter